1AI — Algorae Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
- AU$18.55m
- AU$14.93m
- AU$0.04m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.77 | 0.554 | 0.268 | 0.003 | 0.042 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.21 | 3.3 | 2.28 | 2.39 | 2.13 |
Operating Profit | -3.44 | -2.74 | -2.01 | -2.38 | -2.09 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.48 | -1.35 | -1.91 | -2.37 | -2.11 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.18 | -0.968 | -1.46 | -1.96 | -2.11 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.18 | -0.968 | -1.46 | -1.96 | -2.11 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.18 | -0.968 | -1.46 | -1.96 | -2.11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0.001 | -0.002 | -0.002 | -0.002 |